To more robustly investigate the discriminatory potential of these candidate immune biomarkers, we next performed ROC analysis of IFNγ, TNFα, IL-2, and IL-17A in confirmed TB vs. unlikely TB children in the validation cohort. The gene discussed is IL2; the disease is tuberculosis.